Biofrontera Inc. (BFRI) Q3 2024 Earnings
BFRI·Reported November 13, 2024·After market close
Biofrontera Inc. reported Q3 2024 revenue of $9.0M, missed analyst consensus of $10.0M by $998.0K. Diluted EPS came in at $-0.86, missed the $-0.73 consensus by $0.13.
Revenue
$9.0Mmissed by $998.0K
Consensus: $10.0MDiluted EPS
$-0.86missed by $0.13
Consensus: $-0.73
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Biofrontera Inc.'s Q3 2024 earnings report.
Biofrontera Inc. (BFRI) reported Q3 2024 earnings on November 13, 2024 after market close.
Biofrontera Inc. reported revenue of $9.0M and diluted EPS of $-0.86 for Q3 2024.
Revenue missed the consensus estimate of $10.0M by $998.0K. EPS missed the consensus estimate of $-0.73 by $0.13.
You can read the 10-Q periodic report (0001493152-24-045220) directly on SEC EDGAR. The filing index links above go to sec.gov.